Tomudex (ZD1694, NSC 639186) in platinum-pretreated recurrent epithelial ovarian cancer: A phase II study by the Gynecologic Oncology Group

Franco M. Muggia, John A. Blessing, Howard D. Homesley, Joel Sorosky

Research output: Contribution to journal › Article › peer-review

10 Scopus citations

Fingerprint

Dive into the research topics of 'Tomudex (ZD1694, NSC 639186) in platinum-pretreated recurrent epithelial ovarian cancer: A phase II study by the Gynecologic Oncology Group'. Together they form a unique fingerprint.

Medicine and Dentistry

Keyphrases